| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |